Vulnerable Populations in Immuno-Oncology Research

Vulnerable Populations in Immuno-Oncology Research

kidneycancer

2 weeks
6 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Elad Sharon, MD, MPH Senior Investigator/Medical Officer Cancer Therapy Evaluation Program Division of Cancer Therapy & Diagnosis National Cancer Institute discusses Vulnerable Populations in Immuno-Oncology Research at the 18th International Kidney Cancer Symposium 2019, Miami, FL.
Up Next Autoplay
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Category: Kidney Cancer
8 Views
kidneycancer 22 hours
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Category: Kidney Cancer
0 Views
kidneycancer 23 hours
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Category: Kidney Cancer
3 Views
kidneycancer 1 day
Modern Imaging Technology
Modern Imaging Technology
Category: Kidney Cancer
9 Views
kidneycancer 2 days
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
Category: Kidney Cancer
10 Views
kidneycancer 3 days
Kidney Cancer Program & SPORE
Kidney Cancer Program & SPORE
Category: Kidney Cancer
8 Views
kidneycancer 3 days
Front Line TKI Based Treatment For Non-Clear Cell RCC
Front Line TKI Based Treatment For Non-Clear Cell RCC
Category: Kidney Cancer
31 Views
kidneycancer 1 week
Consolidative Surgery in the IO Era @WinshipAtEmory
Consolidative Surgery in the IO Era @WinshipAtEmory
Category: Kidney Cancer
16 Views
kidneycancer 1 week
Management of Small Renal Masses @RutgersCancer @eric_facs
Management of Small Renal Masses @RutgersCancer @eric_facs
Category: Kidney Cancer
19 Views
kidneycancer 1 week
Cystic Renal Mass Treatment
Cystic Renal Mass Treatment
Category: Kidney Cancer
16 Views
kidneycancer 1 week